Company / Revenue per Share
10x Genomics, Inc. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$5.26
FY2025
5-year range
$2.27 / $5.37
FY2021-FY2025
Trend
+2.5%
vs FY2024
Sector context
#132 of 153
Health Care
What the data says
10x Genomics, Inc.'s revenue per share of $5.26 is lower than 86% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 9 years, ranging from $2.27 in FY2021 to $10.93 in FY2018.
Based on SEC 10-K filings.
5.26 in FY2025 with a 5-year CAGR of +11.1%.
Declined from $5.37 to $5.26 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +25.6%
- 5-Year CAGR
- +11.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 153This company $5.26 Sector average $123.62
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 2.5% year-over-year.
- Ranks #132 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.26 | +2.5% |
| FY2024 | $5.13 | -4.5% |
| FY2023 | $5.37 | +102.2% |
| FY2022 | $2.66 | +17.2% |
| FY2021 | $2.27 | -27.0% |
| FY2020 | $3.11 | -15.7% |
| FY2019 | $3.68 | -66.3% |
| FY2018 | $10.93 | +78.1% |
| FY2017 | $6.13 | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026